AYER, Mass. & PHILADELPHIA--(BUSINESS WIRE)--Cambrooke Therapeutics, Inc. announced it has changed its corporate name to Ajinomoto Cambrooke, Inc. effective April 1, 2019.
In November 2017, Cambrooke became part of Ajinomoto Group when acquired by Ajinomoto Health & Nutrition North America, Inc. Cambrooke’s headquarters and production facilities will remain in Massachusetts. Ajinomoto’s North Carolina production facility will continue to supply Cambrooke’s pharmaceutical-grade amino acids.
For almost 20 years, Cambrooke has been a global leader and innovator in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy. Since its acquisition, Cambrooke has continued its market-leading innovation while benefitting from Ajinomoto’s global nutrition and ingredient sciences expertise and proven flavor and texture enhancing R&D capabilities. Ajinomoto’s expertise has helped Cambrooke further fulfill its mission of improving lives by providing the most delicious and most nutritious medical foods for people with chronic health conditions.
“Our name change reflects the myriad of benefits Ajinomoto helps us to deliver to our customers,” says Howard Lossing, Cambrooke’s CEO. “Ajinomoto’s Eat Well. Live Well. slogan is an elegant summary statement of our mission. Together, we are bringing the best tasting assortment of specialized nutrition products to those we serve.”
About Ajinomoto Health & Nutrition North America, Inc.
Ajinomoto Health & Nutrition North America, Inc. is a wholly-owned subsidiary of Ajinomoto Co., Inc., a global leader in the research, development, manufacture and sale of amino acid-based products for the pharmaceutical, nutraceutical, sports nutrition, health and beauty industries, as well as food ingredients. The company opened its first American office in New York in 1917 and has since grown and expanded its presence, establishing offices and production facilities in North Carolina, Iowa and Illinois. Ajinomoto Health & Nutrition North America, Inc. leverages an international manufacturing, supply and distribution chain to bring the highest-grade products to customers. For additional information on Ajinomoto Health & Nutrition North America, Inc., please visit www.ajinorthamerica.com.
About Ajinomoto Cambrooke, Inc.
Founded in 2000, Cambrooke is a Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious, chronic, unmet medical needs. Today, the company works with physicians and researchers from around the world to develop, test and commercialize products that focus on inborn errors of metabolism, intractable epilepsy and the reduction of malnutrition and weight loss in chronic diseases. More information is available at www.cambrooke.com.
